Atlas Trials

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Clinical trial NCT02381561 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02381561
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7Stage IIA Esophageal Cancer AJCC v7Stage IIA Pancreatic Cancer AJCC v6 and v7Stage IIB Esophageal Cancer AJCC v7Stage IIB Pancreatic Cancer AJCC v6 and v7Stage III Colon Cancer AJCC v7Stage III Esophageal Cancer AJCC v7Stage III Gastric Cancer AJCC v7Stage III Liver CancerStage III Pancreatic Cancer AJCC v6 and v7
Start date
2016-02-01
Primary completion
2018-11-08
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.